QuantumCell ApS
Private limited companyCVR 45663205København KActive
QuantumCell ApS is a private limited company, based in København K, active in manufacture of pharmaceutical preparations, founded in 2025. The company is new and has been registered for 1 years. The latest net result (2025) was a loss of DKK 8.2m.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesManagement and owners, last 24 months
- New in management: Peter Finsel Bisgaard (chair of the board, 07/06/2025), Søren Møller (board member, 15/10/2025) and Christian Ellebæk Elling (board member, 15/10/2025) (+11).
- Stepped down: Peter Høngård Andersen (board member, 15/10/2025), Kasper Lage Hansen (director, 30/11/2025) and Kasper Lage Hansen (board member, 18/09/2026) (+2).
- New owners registered: Lundbeckfond Invest A/S (21/09/2026), Novo Holdings A/S (21/09/2026) and Danmarks Eksport- og Investeringsfond (21/09/2026) (+21).
- No longer registered as owner: Peter Finsel Bisgaard (15/10/2025), Hongaard Holding ApS (15/10/2025) and BHNS Holding ApS (14/10/2025) (+14).
Registrations, last 24 months
- 21/09/2026: Share capital changed from 1,227,310 DKK to 1,518,644 DKK
- 01/09/2026: Moved to Farvergade 10, 4, 1463 København K
- 10/07/2026: Share capital changed from 570,900 DKK to 1,227,310 DKK
- 08/06/2026: Share capital changed from 638,100 DKK to 570,900 DKK
- 26/01/2026: Moved to Nordre Fasanvej 215, 2000 Frederiksberg
- 15/10/2025: Share capital changed from 30,000 DKK to 638,100 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | −8,169 | – |
| Operating profit (EBIT) | −8,781 | – |
| Profit before tax | −9,419 | – |
| Net profit | −8,192 | – |
| Total assets | 31,425 | – |
| Equity | 27,589 | – |
| Liabilities | 3,835 | – |
| Cash and cash equivalents | 29,244 | – |
| Average number of employees | 1 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 07/06/2025 – 31/12/2025 | 09/06/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,613of 69,742 Better than 0% | No. 4,716of 69,964 Better than 93% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 31of 36 Better than 14% | No. 7of 37 Better than 83% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,572of 16,614 Better than 0% | No. 470of 16,661 Better than 97% |
| All companies of type ApS66,508 companies in the comparison | No. 66,263of 66,379 Better than 0% | No. 3,357of 66,505 Better than 95% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- QuantumCell ApS−DKK 8.2m
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- QuantumCell ApS−DKK 8.2m
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- QuantumCell ApSDKK 27.6m
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- QuantumCell ApS4
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Lundbeckfond Invest A/S15%
- Novo Holdings A/S15%
- Danmarks Eksport- og Investeringsfond10%
- Forbion Ventures Fund VII10%
- First Spark Venture Fund, L.P.15%
- Stichting Juridisch eigendom ForCal I5%
- ForDD Ventures VII B.V.5%
Management
9 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Mads Kristian Dalsgaard | Director | 01/08/2026 |
| Saraswati Rudraji Kenkare-Mitra | CEO | 01/08/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Peter Finsel Bisgaard | Chair of the board | 07/06/2025 |
| Søren Møller | Board member | 15/10/2025 |
| Christian Ellebæk Elling | Board member | 15/10/2025 |
| Marco Boorsma | Board member | 15/10/2025 |
| Manish Kothari | Board member | 15/10/2025 |
| Goran Mikael Dolsten | Board member | 06/08/2026 |
| Saraswati Rudraji Kenkare-Mitra | Board member | 18/09/2026 |
- Founders
- Peter Finsel Bisgaard, Hongaard Holding ApS, BHNS Holding ApS
Former management (5)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Peter Høngård Andersen | Board member | 07/06/2025 | 15/10/2025 |
| Kasper Lage Hansen | Director | 07/06/2025 | 30/11/2025 |
| Kasper Lage Hansen | Board member | 07/06/2025 | 18/09/2026 |
| Anta Gkelou | Board member | 15/10/2025 | 08/06/2026 |
| Mads Kristian Dalsgaard | CEO | 01/12/2025 | 31/07/2026 |
Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening, af en direktør i forening med bestyrelsesformanden, eller af den samlede bestyrelse.
Address and production units
1 active production unitsFarvergade 10
1463 København K
| Production unit | Address | Employees | P number |
|---|---|---|---|
| QuantumCell ApS | Farvergade 10, 4, 1463 København K | 4 | 1031399137 |
Purpose
Virksomhedens formål er forskning, udvikling og kommercialisering af lægemidler og anden beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
69 registered events202641 changescapital 3 · ownership 28 · management 7 · address 2 · accounts 1
- CapitalShare capital changed from 1,227,310 DKK to 1,518,644 DKK
- OwnershipLUNDBECKFOND INVEST A/S registered as owner (15%)
- OwnershipForDD Ventures VII B.V. registered as owner (5%)
- OwnershipStichting Juridisch eigendom ForCal I registered as owner (5%)
- OwnershipFirst Spark Venture Fund, L.P. registered as owner (15%)
- OwnershipForbion Ventures Fund VII registered as owner (10%)
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (10%)
- OwnershipNovo Holdings A/S registered as owner (15%)
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipLUNDBECKFOND INVEST A/S is no longer registered as owner
- OwnershipDanmarks Eksport- og Investeringsfond is no longer registered as owner
- OwnershipForbion Ventures Fund VII is no longer registered as owner
- OwnershipFirst Spark Venture Fund, L.P. is no longer registered as owner
- OwnershipStichting Juridisch eigendom ForCal I is no longer registered as owner
- OwnershipForDD Ventures VII B.V. is no longer registered as owner
- ManagementSaraswati Rudraji Kenkare-Mitra appointed board member
- ManagementKasper Lage Hansen stepped down as board member
- AddressMoved to Farvergade 10, 4, 1463 København K
- ManagementGoran Mikael Dolsten appointed board member
- ManagementSaraswati Rudraji Kenkare-Mitra appointed ceo
- ManagementMads Kristian Dalsgaard appointed director
- ManagementMads Kristian Dalsgaard stepped down as ceo
- CapitalShare capital changed from 570,900 DKK to 1,227,310 DKK
- OwnershipNovo Holdings A/S registered as owner (15%)
- OwnershipLUNDBECKFOND INVEST A/S registered as owner (15%)
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (5%)
- OwnershipForbion Ventures Fund VII registered as owner (5%)
- OwnershipFirst Spark Venture Fund, L.P. registered as owner (15%)
- OwnershipStichting Juridisch eigendom ForCal I registered as owner (5%)
- OwnershipBHNS Holding ApS is no longer registered as owner
- OwnershipTrophic Aps is no longer registered as owner
- OwnershipLUNDBECKFOND INVEST A/S is no longer registered as owner
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipFirst Spark Venture Fund, L.P. is no longer registered as owner
- OwnershipForbion Ventures Fund VII is no longer registered as owner
- AccountsAnnual report for 2025 published
- CapitalShare capital changed from 638,100 DKK to 570,900 DKK
- ManagementAnta Gkelou stepped down as board member
- OwnershipSofinnova Capital XI SCSp SICAV-RAIF is no longer registered as owner
- OwnershipForDD Ventures VII B.V. registered as owner (5%)
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
202528 changesmanagement 12 · name 1 · capital 1 · ownership 13 · founded 1
- ManagementMads Kristian Dalsgaard appointed ceo
- ManagementKasper Lage Hansen stepped down as director
- NameName changed from qCell ApS to QuantumCell ApS
- CapitalShare capital changed from 30,000 DKK to 638,100 DKK
- ManagementChristian Ellebæk Elling appointed board member
- ManagementAnta Gkelou appointed board member
- ManagementSøren Møller appointed board member
- ManagementMarco Boorsma appointed board member
- ManagementManish Kothari appointed board member
- ManagementPeter Høngård Andersen stepped down as board member
- OwnershipLUNDBECKFOND INVEST A/S registered as owner (10%)
- OwnershipNovo Holdings A/S registered as owner (20%)
- OwnershipFirst Spark Venture Fund, L.P. registered as owner (15%)
- OwnershipSofinnova Capital XI SCSp SICAV-RAIF registered as owner (10%)
- OwnershipBHNS Holding ApS registered as owner (5%)
- OwnershipForbion Ventures Fund VII registered as owner (15%)
- OwnershipTrophic Aps registered as owner (5%)
- OwnershipHongaard Holding ApS is no longer registered as owner
- OwnershipPeter Finsel Bisgaard is no longer registered as owner
- OwnershipBHNS Holding ApS is no longer registered as owner
- FoundedRegistered as qCell ApS
- ManagementPeter Høngård Andersen appointed board member
- ManagementPeter Finsel Bisgaard appointed chair of the board
- ManagementKasper Lage Hansen appointed board member
- ManagementKasper Lage Hansen appointed director
- OwnershipHongaard Holding ApS registered as owner (33.33%)
- OwnershipBHNS Holding ApS registered as owner (33.33%)
- OwnershipPeter Finsel Bisgaard registered as owner (33.33%)
Related companies
Same industry in København
- H. Lundbeck A/S2,261 employees
- AJ Vaccines A/S499 employees
- Tetra Pharm Technologies ApS39 employees
- Motilitycount ApS29 employees
- Freya Biosciences ApS18 employees
- Zerion Pharma A/S15 employees
Same people in management
- H. Lundbeck A/Svia Peter Høngård Andersen
- NMD Pharma A/Svia Christian Ellebæk Elling
- Glycom A/Svia Peter Høngård Andersen
- 21st.BIO A/Svia Søren Møller
- SNIPR Biome ApSvia Christian Ellebæk Elling
- Orbis Medicines ApSvia Søren Møller
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.